15Holders
0.00%Avg. Weight
$0.2BTotal Value
0New Buys
Price Chart
EE
EELoading...
Fundamentals
Market Cap$4.07B
P/E Ratio103.94x
EPS$1.31
52W High$43.17
52W Low$21.29
Dividend Yield0.88%
SectorEnergy
ExchangeNEW YORK STOCK EXCHANGE, INC.
Smart Money Score
Holders (15)
13F · by weight| # | Investor | Weight | Shares | Value | Activity |
|---|---|---|---|---|---|
| 1 |  Jim Simons (Estate) Renaissance Technologies LLC | 0.01% | 285,519 | $9.54M | HOLD |
| 2 |  David E. Shaw D.E. Shaw & Co LP | 0.01% | 343,491 | $11.48M | HOLD |
| 3 |  Ray Dalio Bridgewater Associates LP | 0.01% | 38,675 | $1.29M | HOLD |
| 4 |  Two Sigma Two Sigma Investments LP | 0.00% | 130,542 | $4.36M | HOLD |
| 5 |  Paul Tudor Jones Tudor Investment Corp | 0.00% | 40,339 | $1.35M | HOLD |
| 6 |  Fidelity (FMR) Fidelity Management & Research | 0.00% | 838,987 | $28.04M | HOLD |
| 7 |  Steve Cohen Point72 Asset Management LP | 0.00% | 28,892 | $965,571 | HOLD |
| 8 |  BlackRock BlackRock Inc | 0.00% | 1,892,184 | $63.24M | HOLD |
| 9 |  JPMorgan Chase JPMorgan Asset Management | 0.00% | 439,660 | $14.65M | HOLD |
| 10 |  Goldman Sachs Goldman Sachs Asset Management | 0.00% | 242,837 | $8.12M | HOLD |
| 11 |  State Street State Street Global Advisors | 0.00% | 552,117 | $18.45M | HOLD |
| 12 |  Cliff Asness AQR Capital Management LLC | 0.00% | 41,281 | $1.38M | HOLD |
| 13 |  Israel Englander Millennium Management LLC | 0.00% | 26,844 | $897,126 | HOLD |
| 14 |  Ken Griffin Citadel Advisors LLC | 0.00% | 40,855 | $1.37M | HOLD |
| 15 |  T. Rowe Price T. Rowe Price Associates | 0.00% | 18,030 | $603,000 | HOLD |
Related Articles (5)
Dynatrace & TEAM Inc Report Earnings — 25 SEC 8-K Filings Received Today · 5/14/2026
25 Companies File Earnings Disclosures Including ITT, Steve Madden Amid Tariff Uncertainty · 5/7/2026
Emerging Markets Hit Record High: KOSPI +57%, Taiwan +34%, Brazil +16%—3x S&P 500's GainMacro · 5/4/2026
JPMorgan & Susquehanna Sharply Raise Bloom Energy Price Targets — Still Bullish After 1,400% Rally · 4/30/2026
FDA Launches AI-Powered Real-Time Clinical Trial Tracking Initiative, Targeting 20–40% Reduction in Drug Development TimelinesMacro · 4/29/2026